10-Q: One World Products Pivots to Bio-Plastics Amid Going Concern

One World Products, soon to be Isiah Enterprises, Inc., is strategically shifting its focus to bio-sustainable plastics through an acquisition, despite facing severe liquidity challenges and a going concern warning.

Summary

• The company is changing its corporate name to Isiah Enterprises, Inc., a change approved in July 2025 and pending FINRA approval.
• Acquired substantially all assets of Eco Bio Plastics Midland, Inc. for $515,000 in cash, with $415,000 paid at closing on July 11, 2025, marking a strategic pivot to bio-sustainable plastics.
• The new business focus is on industrial compounding for food packaging, automotive, and consumer goods sectors, utilizing proprietary formulations and scalable manufacturing.
• Reported a net loss of $(521,582) for the six months ended June 30, 2025, a significant improvement from $(2,566,081) in the prior year period.
• Cash on hand was critically low at $13,615 as of June 30, 2025, a decrease from $42,456 at December 31, 2024.
• The accumulated deficit increased to $(31,386,280) from $(30,864,698) at December 31, 2024.
• Management concluded that disclosure controls and procedures were not effective as of June 30, 2025.
• The company's Colombian subsidiary, OWP SAS, entered into liquidation proceedings effective October 1, 2024.

Sentiment

Score: 3

Explanation: While the net loss improved and a strategic pivot to a promising industry (bio-plastics) occurred, the company faces severe liquidity issues, a going concern warning, and ineffective internal controls. The reliance on related-party financing and the early stage of the new business temper any optimism from the strategic shift and reduced losses.

Positives

• Net loss significantly decreased to $(521,582) for the six months ended June 30, 2025, from $(2,566,081) in the prior year, primarily due to the absence of one-time losses from early debt extinguishment and deconsolidation of foreign subsidiaries.
• Operating loss improved to $(304,629) for the six months ended June 30, 2025, from $(1,150,712) in the prior year.
• Strategic acquisition of Eco Bio Plastics Midland, Inc. assets provides proprietary formulations and scalable manufacturing capacity for bio-sustainable plastics, aligning with growing ESG trends.
• The new business focus on industrial compounding for automotive, food packaging, and consumer goods offers a potentially larger and more relevant market than the previous CBD sales segment.
• Development of hemp-based molded containers for automotive part packaging applications demonstrates innovation in the new strategic direction.

Negatives

• Cash on hand is critically low at $13,615 as of June 30, 2025, indicating severe liquidity constraints.
• Negative working capital of $3,198,254 as of June 30, 2025, highlights an inability to cover short-term liabilities with current assets.
• The accumulated deficit increased to $31,386,280, reflecting ongoing losses.
• Management explicitly states "substantial doubt about the Company's ability to continue as a going concern" without additional financing.
• Revenues from the previous CBD business segment remain minimal ($1,653 for six months ended June 30, 2025) and this segment is no longer being pursued.
• Disclosure controls and procedures were concluded to be "not effective" as of June 30, 2025, raising concerns about financial reporting reliability.
• Significant reliance on related party debt for financing operations and acquisitions poses concentration and potential conflict of interest risks.

Risks

• Going Concern Uncertainty: The company's ability to continue as a going concern is in substantial doubt due to critically low cash, negative working capital, and accumulated deficit, requiring significant additional financing.
• Capital Raising Dependence: Future growth, scaling of production, and continued operations are largely dependent on successfully raising additional capital, with no assurance of securing such funds.
• New Business Venture Risk: The strategic pivot to bio-sustainable plastics and industrial hemp is in its early development stage, with no guarantee of generating significant revenues or achieving profitability.
• Ineffective Disclosure Controls: Management concluded that disclosure controls and procedures were not effective, which could lead to material misstatements or failures in financial reporting and compliance.
• Related Party Dependence: Heavy reliance on debt financing from related parties (CEO, significant shareholders) introduces potential conflicts of interest, concentration risk, and may not be sustainable long-term.
• Liquidation of Foreign Subsidiary: The Colombian subsidiary (OWP SAS) is in liquidation proceedings, which, while not expected to materially impact the company's financial statements, indicates past operational and financial challenges.
• Legal Proceedings: OWP SAS is involved in 23 lawsuits in Colombia with an estimated potential liability of $310,000, which the company states will not become its responsibility, but still represents a contingent exposure for the subsidiary.
• Dilution Risk: The approved increase in authorized common stock to 1,000,000,000 shares provides flexibility for future equity raises but poses a significant risk of dilution for existing common shareholders.
• Market Acceptance: Success of new bio-sustainable products depends on market acceptance and competition with traditional materials and other eco-friendly alternatives.

Future Outlook

The company is pivoting its business focus to bio-sustainable solutions, specifically plant-based and biodegradable plastics, following the acquisition of Eco Bio Plastics Midland, Inc. It aims to produce hemp-based materials for automotive, food packaging, and consumer goods applications. The company is actively seeking to raise additional capital to fund research, development, and scale production capabilities for these new ventures. The corporate name change to Isiah Enterprises, Inc. and an increase in authorized common stock are also planned to support this strategic shift.

Management Comments

• "We are currently focused on research and development activities involving bio-sustainable solutions. These solutions enable automakers to reduce their carbon footprint and support environmental initiatives within the automotive supply chain."
• "We are actively seeking to raise capital and further research and development in this area. If successful, we intend to produce these hemp-based materials for a variety of applications, starting with automotive component applications."
• "With the acquisition of Eco Bio, a Midland, Michigan-based manufacturer of plant-based and biodegradable plastics and its developing industrial solutions business targeting the automotive market, we are now focused on industrial compounding food packaging, automotive, and consumer goods sectors."
• "Eco Bio Plastics brings proprietary formulations and scalable manufacturing capacity that will support our transition into a vertically integrated sustainable materials company."
• "Our ability to scale production and distribution capabilities and further increase the value of our brands is largely dependent on our success in raising additional capital."
• "There can be no assurance that we will be successful in achieving these objectives; therefore, without sufficient financing it would be unlikely for the Company to continue as a going concern."

Industry Context

The company's pivot to bio-sustainable plastics aligns with growing global trends towards environmental, social, and governance (ESG) initiatives and demand for eco-friendly materials, particularly in the automotive, food packaging, and consumer goods sectors. This move positions the company to potentially capitalize on the increasing pressure for industries to reduce carbon footprints and adopt biodegradable alternatives. The previous CBD business, which is no longer being pursued, faced a highly competitive and evolving market. The new focus, while promising, will require significant capital and successful market penetration against established materials and competitors.

Comparison to Industry Standards

• The company's financial health, characterized by critically low cash ($13,615), negative working capital ($3,198,254), and a substantial accumulated deficit ($31,386,280), is significantly below the standards typically expected for publicly traded companies, especially those seeking to scale new industrial ventures.
• The heavy reliance on related-party debt for operational funding and acquisition financing is not a standard practice for financially robust public entities and suggests limited access to traditional capital markets.
• The strategic pivot to bio-sustainable plastics, while aligning with broader ESG trends, places the company in an emerging and competitive market where established players or well-funded startups often have significant advantages in R&D, production scale, and market penetration.
• The filing highlights Eco Bio's proprietary micronization and pelletization process as producing the "only pelletized bast fiber on the market," suggesting a unique technological offering, but the filing does not provide specific comparable companies or projects to benchmark this claim against.

Management Changes

Corporate Governance

Legal Proceedings

• OWP SAS (Colombian subsidiary) entered into liquidation proceedings effective October 1, 2024, under Colombian Law 1116 of 2006.
• OWP SAS is involved in 23 separate lawsuits for civil and labor disputes in Colombia, with an estimated potential liability of approximately $310,000 to OWP SAS, which the company states will not become its responsibility.

Related Party Transactions

• Debt Financing: Received $400,000 from Dr. John McCabe (significant shareholder) in April 2025 for a 10% interest promissory note, due on demand.
• Debt Financing: Received $20,000 from Isiah L. Thomas, III (Chairman & CEO) in April 2025 for a 10% interest unsecured promissory note, due on demand.
• Debt Financing: Issued a $10,000 unsecured promissory note to Isiah L. Thomas, III on March 24, 2025, due on demand, 10% interest.
• Debt Financing: Issued a $10,000 unsecured promissory note to Isiah L. Thomas, III on April 2, 2025, due on demand, 10% interest.
• Debt Financing: Issued a $50,000 unsecured promissory note to John McCabe on April 7, 2025, due on demand, 10% interest.
• Debt Financing: Issued a $250,000 unsecured promissory note to John McCabe on April 21, 2025, due on demand, 10% interest.
• Debt Financing: Issued a $100,000 unsecured promissory note to John McCabe on June 30, 2025, due on demand, 10% interest.
• Debt Financing (Subsequent Event): Received $40,000 and $20,000 from an affiliate of Isiah L. Thomas, III on July 15 and July 22, 2025, respectively, for 10% interest unsecured promissory notes, due on demand.
• Debt Financing (Subsequent Event): Dr. John McCabe committed to a $1,500,000 secured Exchange Note and Deed of Trust, including $500,000 already advanced and future commitments, bearing 12% interest and due January 31, 2027 (or extended to 2028).
• Common Stock Issued for Services: Issued 882,353 shares of common stock to the CFO on June 25, 2025, with a fair value of $15,000.
• Common Stock Issued for Services: Issued 694,445 shares of common stock to the CFO on March 25, 2025, with a fair value of $15,000.
• Accounts Payable: Total amount due to one of the company's directors was $27,977 at June 30, 2025.

Stakeholder Impact

• Shareholders: Potential for significant dilution due to the approved increase in authorized common stock and ongoing need for capital raises. The Series C Preferred Stock concentrates voting power. The going concern warning poses a significant risk to investment value.
• Employees: Appointment of Fukuji Saotome as COO of the new subsidiary indicates new employment opportunities in the bio-plastics segment. However, the overall financial instability could create job insecurity.
• Creditors: Related party creditors (Isiah L. Thomas, III, Dr. John McCabe) are providing substantial financing, but the company's going concern status and high debt levels pose repayment risks. The secured note for Dr. McCabe provides collateral for his advances.
• Customers: The strategic pivot to bio-sustainable plastics aims to serve new customers in automotive, food packaging, and consumer goods, offering ESG-compliant alternatives. The previous CBD customers are no longer a focus.
• Suppliers: The new business focus will involve new supply chains for plant-based materials and manufacturing, potentially creating opportunities for new suppliers.

Next Steps

• FINRA approval for the corporate name change to Isiah Enterprises, Inc.
• Increase in authorized common stock to 1,000,000,000 shares, expected on or before November 1, 2025.
• Actively seeking additional capital to fund operations and scale the new bio-sustainable solutions business.
• Integration and development of Eco Bio Plastics Midland, Inc. assets for industrial compounding.
• Fukuji Saotome to serve as COO of EBPIE, LLC, with stock options vesting over several years.
• Further funding from Dr. John McCabe for the Eco Bio acquisition and operations ($60,000 by Aug 4, 2025, $90,000 by Aug 18, 2025, $150,000 by Sep 12, 2025, and a future $75,000 commitment).

Key Dates

Recommendation

The company faces severe financial distress, evidenced by critically low cash ($13,615), negative working capital ($3.2 million), and an accumulated deficit ($31.4 million). The explicit "going concern" warning indicates a high risk of business failure without substantial, uncertain future financing. While the strategic pivot to bio-sustainable plastics and the acquisition of Eco Bio Plastics Midland, Inc. offer a potentially promising new direction, this venture is in its early stages and requires significant capital, which the company currently lacks. The reliance on related-party debt, ineffective disclosure controls, and the potential for massive shareholder dilution from the authorized capital increase further exacerbate the risk profile. Despite an improved net loss compared to the prior year, the underlying financial health remains extremely weak, making the stock a high-risk, speculative investment with a strong likelihood of further value erosion.

Keywords

Bio-sustainable plastics, Hemp-based materials, Eco Bio Plastics Midland, Isiah Enterprises, SEC 10-Q, Quarterly Report, Going Concern, Capital Raise, Corporate Name Change, Fukuji Saotome, Industrial Compounding, Automotive Supply Chain, Financial Reporting, Corporate Governance, Liquidity